| Molecular pathology of thyroid tumours of follicular cells: a review of genetic alterations and their clinicopathological relevance G Acquaviva, M Visani, A Repaci, KJ Rhoden, D de Biase, A Pession, ... Histopathology 72 (1), 6-31, 2018 | 122 | 2018 |
| TERT Promoter Mutations in Papillary Thyroid Microcarcinomas D de Biase, G Gandolfi, M Ragazzi, M Eszlinger, V Sancisi, M Gugnoni, ... Thyroid 25 (9), 1013-1019, 2015 | 118 | 2015 |
| Expression of 19 microRNAs in glioblastoma and comparison with other brain neoplasia of grades I–III M Visani, D De Biase, G Marucci, S Cerasoli, E Nigrisoli, MLB Reggiani, ... Molecular oncology 8 (2), 417-430, 2014 | 115 | 2014 |
| Possible association between hepatitis C virus and malignancies different from hepatocellular carcinoma: A systematic review S Fiorino, L Bacchi-Reggiani, D De Biase, A Fornelli, M Masetti, A Tura, ... World journal of gastroenterology 21 (45), 12896, 2015 | 108 | 2015 |
| Next-generation sequencing of lung cancer EGFR exons 18-21 allows effective molecular diagnosis of small routine samples (cytology and biopsy) D de Biase, M Visani, U Malapelle, F Simonato, V Cesari, C Bellevicine, ... PloS one 8 (12), e83607, 2013 | 97 | 2013 |
| High-Sensitivity BRAF Mutation Analysis: BRAF V600E Is Acquired Early During Tumor Development but Is Heterogeneously Distributed in a Subset of Papillary … D de Biase, V Cesari, M Visani, GP Casadei, N Cremonini, G Gandolfi, ... The Journal of Clinical Endocrinology & Metabolism 99 (8), E1530-E1538, 2014 | 88 | 2014 |
| Role of microRNAs in the main molecular pathways of hepatocellular carcinoma F Vasuri, M Visani, G Acquaviva, T Brand, M Fiorentino, A Pession, ... World journal of gastroenterology 24 (25), 2647, 2018 | 86 | 2018 |
| MicroRNAs as possible biomarkers for diagnosis and prognosis of hepatitis B-and C-related-hepatocellular-carcinoma S Fiorino, ML Bacchi-Reggiani, M Visani, G Acquaviva, A Fornelli, ... World journal of gastroenterology 22 (15), 3907, 2016 | 85 | 2016 |
| Cytokine storm in aged people with CoV-2: possible role of vitamins as therapy or preventive strategy S Fiorino, C Gallo, M Zippi, S Sabbatani, R Manfredi, R Moretti, E Fogacci, ... Aging clinical and experimental research 32, 2115-2131, 2020 | 80 | 2020 |
| Next generation sequencing improves the accuracy of KRAS mutation analysis in endoscopic ultrasound fine needle aspiration pancreatic lesions D de Biase, M Visani, P Baccarini, AM Polifemo, A Maimone, A Fornelli, ... PloS one 9 (2), e87651, 2014 | 75 | 2014 |
| Allele Specific Locked Nucleic Acid Quantitative PCR (ASLNAqPCR): An Accurate and Cost-Effective Assay to Diagnose and Quantify KRAS and BRAF Mutation L Morandi, D de Biase, M Visani, V Cesari, G De Maglio, S Pizzolitto, ... PloS one 7 (4), e36084, 2012 | 71 | 2012 |
| BRAF V600E and risk stratification of thyroid microcarcinoma: a multicenter pathological and clinical study G Tallini, D De Biase, C Durante, G Acquaviva, M Bisceglia, R Bruno, ... Modern Pathology 28 (10), 1343-1359, 2015 | 65 | 2015 |
| Molecular diagnostic of solid tumor using a next generation sequencing custom-designed multi-gene panel D de Biase, G Acquaviva, M Visani, V Sanza, CM Argento, A De Leo, ... Diagnostics 10 (4), 250, 2020 | 47 | 2020 |
| Mutant BRAF in low‐grade epilepsy‐associated tumors and focal cortical dysplasia G Marucci, D de Biase, M Visani, M Giulioni, M Martinoni, L Volpi, ... Annals of Clinical and Translational Neurology 1 (2), 130-134, 2014 | 41 | 2014 |
| Long-term survivors of pancreatic adenocarcinoma show low rates of genetic alterations in KRAS, TP53 and SMAD4 M Masetti, G Acquaviva, M Visani, G Tallini, A Fornelli, M Ragazzi, ... Cancer Biomarkers 21 (2), 323-334, 2018 | 40 | 2018 |
| miRNAs expression analysis in paired fresh/frozen and dissected formalin fixed and paraffin embedded glioblastoma using real-time pCR D De Biase, M Visani, L Morandi, G Marucci, C Taccioli, S Cerasoli, ... PLoS One 7 (4), e35596, 2012 | 37 | 2012 |
| Fully automated PCR detection of KRAS mutations on pancreatic endoscopic ultrasound fine-needle aspirates D De Biase, C de Luca, G Gragnano, M Visani, C Bellevicine, U Malapelle, ... Journal of Clinical Pathology 69 (11), 986-991, 2016 | 34 | 2016 |
| Targeted BRAF and CTNNB1 next-generation sequencing allows proper classification of nonadenomatous lesions of the sellar region in samples with limiting … G Marucci, D de Biase, M Zoli, M Faustini-Fustini, A Bacci, E Pasquini, ... Pituitary 18, 905-911, 2015 | 34 | 2015 |
| Definition of miRNAs expression profile in glioblastoma samples: the relevance of non-neoplastic brain reference M Visani, D De Biase, G Marucci, C Taccioli, A Baruzzi, A Pession, ... PloS one 8 (1), e55314, 2013 | 32 | 2013 |
| Genome-wide profiling identifies the THYT1 signature as a distinctive feature of widely metastatic Papillary Thyroid Carcinomas G Gandolfi, M Ragazzi, D de Biase, M Visani, E Zanetti, F Torricelli, ... Oncotarget 9 (2), 1813, 2018 | 31 | 2018 |
Dario de BiaseUniversity of BolognaVerified email at unibo.it
Dario de BiaseUniversity of BolognaVerified email at unibo.it